Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study.
Saved in:
| Title: | Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study. |
|---|---|
| Authors: | Matsumori, Yasuhiko1 (AUTHOR), Nagy, Krisztian2 (AUTHOR) krisztian.nagy@abbvie.com, Takahashi, Akihiro3 (AUTHOR), Tanaka, Shigeya4 (AUTHOR), Takeshima, Takao5 (AUTHOR), Forero, Giovanna2 (AUTHOR), Bao, Jia2 (AUTHOR), Guo, Hua2 (AUTHOR), Ahmadyar, Gina2 (AUTHOR), de Abreu Ferreira, Rosa2 (AUTHOR), Yamamoto, Toshimasa6 (AUTHOR) |
| Source: | Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p1137-1154. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
